I'll replace MITI with MACK, PCYC with ARQL. I still like Ibutinib a lot, have to take profit after big run like that. Here is updated list:
1. Generic/biosimilar/biobetter: PLX, MNTA
Jq, sounds like PLX disclosed a few new drugs today. What, IYO, are the most important assets for PLX that we should keep an eye on? I'd like to take a closer look at them.